The biotech sector is thriving with innovative startups focused on groundbreaking advancements in healthcare, genomics, and precision medicine. These 20 biotech companies, founded after 2020, have secured $5M to $10M in funding to scale their transformative research and therapies.
From gene editing to cell-based treatments and biomarker discovery, these startups are on the cutting edge of medical science and are poised to revolutionize the healthcare landscape.
Meet the 20 Biotech Startups Making Waves with $5M–$10M in Funding
Explore how these biotech startups are accelerating advancements in life sciences and shaping the future of medicine.
| Company Name | Founded | Location | Number of Employees | Last Funding | Last Funding Date | Total Funding |
|---|---|---|---|---|---|---|
| Biosphere | 2022 | Oakland, CA, USA | 11-50 | $8.8M | Jan 9, 2025 | $8.8M |
| Genflow Biosciences | 2020 | Cambridge, MA, USA | 1-10 | €2.81M | Oct 22, 2024 | $5.66M |
| Aarvik Therapeutics | 2020 | Fremont, CA, USA | 11-50 | $1.17M | Dec 10, 2024 | $9.5M |
| UNCAGED Innovations | 2020 | White Plains, NY, USA | 1-10 | $5.6M | Jul 2, 2024 | $7.85M |
| Paterna Biosciences | 2020 | Salt Lake City, USA | 11-50 | $6.4M | Oct 28, 2024 | $6.4M |
| NILO Therapeutics | 2024 | New York, NY, USA | 1-10 | $9.6M | Aug 2, 2024 | $9.6M |
| CrossBridge Bio | 2023 | Houston, TX, USA | 1-10 | $10M | Nov 4, 2024 | $10M |
| Tagomics | 2020 | Cambridge, UK | 1-10 | £6.7M | Feb 21, 2024 | $8.5M |
| Kano Therapeutics | 2021 | Cambridge, USA | 1-10 | $5M | Aug 12, 2024 | $7.1M |
| Transcripta Bio | 2020 | Palo Alto, USA | 11-50 | $10M | Apr 29, 2024 | $10M |
| Macro Oceans | 2020 | San Francisco, USA | 1-10 | $2.5M | Sep 30, 2024 | $7.5M |
| Anebulo Pharmaceuticals | 2020 | Austin, USA | 1-10 | $1.9M | Nov 13, 2024 | $9.4M |
| Prolocor | 2020 | Philadelphia, USA | 1-10 | $1.7M | Feb 27, 2024 | $6.9M |
| Catena Biosciences | 2020 | Berkeley, USA | 1-10 | $2.35M | May 10, 2024 | $8.05M |
| Acenxion Biosystems | 2020 | Lawrence, KS, USA | 1-10 | $1.07M | Aug 14, 2024 | $5.32M |
| Predicta Biosciences | 2023 | Boston, USA | 1-10 | $5.2M | Jul 16, 2024 | $5.2M |
| Steel Therapeutics | 2020 | North Liberty, USA | 1-10 | $2M | Dec 5, 2024 | $7.1M |
| TwoStep Therapeutics | 2023 | Palo Alto, USA | 1-10 | $6.5M | Jun 25, 2024 | $6.5M |
| Previse (Capsulomics) | 2020 | Baltimore, USA | 11-50 | $1.8M | Oct 22, 2024 | $8.05M |
| CellVax Therapeutics | 2020 | Miami, FL, USA | 1-10 | $2.08M | Oct 4, 2024 | $7.31M |
1. Biosphere
- Founded: 2022
- Location: Oakland, California
- Industry: Biotechnology (Manufacturing)
- Number of Employees: 11-50
- Total Funding Amount: $8.8 Million
- Last Funding Amount: $8.8 Million (Latest Round: January 9, 2025)
Biosphere is at the forefront of innovative biotechnology solutions, specializing in commercial-scale fermentation products and cutting-edge robotic greenhouses. Based in Oakland, California, Biosphere is committed to revolutionizing the manufacturing of sustainable food and agricultural products through advanced technologies.
The company combines biotechnology with automation, enabling efficient production and distribution of high-quality, eco-friendly products. Their use of fermentation techniques and robotic systems in greenhouses optimizes agricultural practices, leading to higher yields, reduced waste, and a smaller environmental footprint.
2. Genflow Biosciences
- Founded: 2020
- Location: Cambridge, Massachusetts
- Industry: Biotechnology (Health Care)
- Number of Employees: 1-10
- Total Funding Amount: $5.66 Million
- Last Funding Amount: €2.81 Million (Latest Round: October 22, 2024)
GenFlow Biosciences is a cutting-edge synthetic biology company focused on developing gene therapies that aim to delay or reverse the aging process in both humans and canines. Based in Cambridge, Massachusetts, the company is committed to advancing life-extending therapies that not only target aging but also combat diseases associated with aging and advanced age.
With a strong dedication to innovation, GenFlow Biosciences is paving the way for transformative breakthroughs in longevity. The company’s primary mission is to extend life expectancy and improve the quality of life by developing treatments that slow or reverse aging, offering a promising future for both humans and dogs.
3. Aarvik Therapeutics
- Founded: 2020
- Location: Fremont, California
- Industry: Biotechnology (Life Science)
- Number of Employees: 11-50
- Total Funding Amount: $9.5 Million
- Last Funding Amount: $1.17 Million (Latest Round: December 10, 2024)
Aarvik Therapeutics is a pioneering biotechnology company focused on engineering precision therapies for oncology targets. Using a proprietary modular platform, Aarvik develops novel molecules designed to improve therapeutic indices for various cancer-related targets.
The company leverages its founders’ and Board members’ extensive experience in scientific research, development, and investment to drive innovative solutions in the fight against cancer. Aarvik’s vision is to deliver transformational benefits for cancer patients by addressing the unmet needs in oncology through highly targeted and efficient treatments.
4. UNCAGED Innovations
- Founded: 2020
- Location: White Plains, New York
- Industry: Biotechnology (Sustainability)
- Number of Employees: 1-10
- Total Funding Amount: $7.85 Million
- Last Funding Amount: $5.6 Million (Latest Round: July 2, 2024)
UNCAGED Innovations is a cutting-edge biomaterials company at the forefront of sustainable innovation. The company specializes in developing next-generation materials to recreate bovine and exotic leather through advancements in materials chemistry and digital manufacturing. Their innovative approach offers industries such as luxury fashion, automotive, and other consumer goods a sustainable and ethical alternative to traditional animal skin.
By combining the power of nature with advanced technology, UNCAGED Innovations is reimagining leather, making it possible to create high-quality, animal-free materials that maintain the performance and luxury appeal of real leather. Their solutions provide an eco-friendly choice for businesses looking to embrace sustainability while maintaining premium standards.
5. Paterna Biosciences
- Founded: 2020
- Location: Salt Lake City
- Industry: Biotechnology
- Number of Employees: 11-50
- Total Funding Amount: $6.4 Million
- Last Funding Amount: $6.4 Million (Latest Round: Oct 28, 2024)
Paterna Biosciences is a groundbreaking biotechnology startup specializing in improving male reproductive health at the cellular level. With a vision to address the growing demand for fertility solutions, the company is pioneering research into male fertility optimization and is committed to transforming the fertility landscape.
By focusing on cellular-level interventions, Paterna Biosciences is developing treatments designed to enhance sperm quality, motility, and overall reproductive function. The company’s innovative approach enables it to offer tailored solutions for male reproductive issues, complementing traditional fertility treatments for both men and women.
6. NILO Therapeutics
- Founded: 2024
- Location: New York
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $9.6 Million
- Last Funding Amount: $9.6 Million (Latest Round: Aug 2, 2024)
NILO Therapeutics is an emerging biotechnology company focused on developing groundbreaking therapeutics to address unmet medical needs. With a mission to revolutionize the field of life sciences, NILO Therapeutics aims to provide innovative solutions for a range of diseases with high unmet demand, leveraging the latest advancements in biotechnology.
The company specializes in creating next-generation treatments that integrate cutting-edge technologies with precision medicine. By targeting specific molecular pathways and disease markers, NILO Therapeutics seeks to develop more effective and personalized therapies for its patients.
7. CrossBridge Bio
- Founded: 2023
- Location: Houston, Texas
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $10 Million
- Last Funding Amount: $10 Million (Latest Round: Nov 4, 2024)
CrossBridge Bio is a cutting-edge biotechnology company committed to accelerating advancements in the life sciences industry. The company is focused on developing innovative therapeutic solutions for a variety of complex diseases, leveraging a mix of biotechnology and advanced research methods to push the boundaries of modern medicine.
With an emphasis on delivering therapies that address key unmet medical needs, CrossBridge Bio combines deep scientific expertise with a forward-thinking approach to tackle the most pressing health challenges of today. Their team is at the forefront of biotechnology, developing treatments that offer new hope to patients worldwide.
8. Tagomics
- Founded: 2020
- Location: Cambridge, UK
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: £6.7 Million (Approx. $8.5 Million USD)
- Last Funding Amount: £6.7 Million (Latest Round: Feb 21, 2024)
Tagomics is an innovative biotechnology company specializing in advanced genomic profiling and biomarkers to transform the precision medicine landscape. The company’s cutting-edge technology platform enables detailed molecular analysis that allows for more personalized, efficient, and targeted treatment approaches.
By leveraging advanced techniques in genomics and molecular biology, Tagomics aims to advance healthcare by providing solutions that improve diagnostic accuracy and optimize therapeutic outcomes. The company is particularly focused on advancing treatments in oncology, immune diseases, and beyond, working to harness the power of molecular data for the betterment of patient care.
9. Kano Therapeutics
- Founded: 2021
- Location: Cambridge, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $7.1 Million
- Last Funding Amount: $5 Million (Latest Round: Aug 12, 2024)
Kano Therapeutics is a pioneering biotechnology company focused on developing novel therapeutic solutions for central nervous system (CNS) disorders. By combining cutting-edge technology and a deep understanding of the molecular biology of neurological diseases, Kano Therapeutics aims to bring transformative treatments to patients suffering from a range of neurodegenerative conditions.
The company’s approach integrates advanced gene therapies and neuromodulation techniques to target the underlying causes of disorders like Alzheimer’s, Parkinson’s, and multiple sclerosis, offering hope for more effective treatments with fewer side effects. Through innovative research and the application of breakthrough technologies, Kano Therapeutics is striving to reshape the landscape of CNS treatment and provide better outcomes for patients worldwide.
10. Transcripta Bio
- Founded: 2020
- Location: Palo Alto, USA
- Industry: Biotechnology
- Number of Employees: 11-50
- Total Funding Amount: $10 Million
- Last Funding Amount: $10 Million (Latest Round: Apr 29, 2024)
Transcripta Bio is a cutting-edge biotechnology company revolutionizing drug discovery by focusing on accelerating the development of therapeutics at an unprecedented pace and scale. The company is using advanced technologies to work across multiple disease targets simultaneously, minimizing risks and optimizing the discovery process.
With a focus on creating breakthrough therapies, Transcripta Bio utilizes innovative methods to speed up the drug development timeline, ensuring that more promising treatments make it to the market faster and with greater success rates. Their approach is built on precision, scalability, and high-throughput capabilities, enabling them to tackle a broad spectrum of diseases, ultimately improving the lives of patients globally.
11. Macro Oceans
- Founded: 2020
- Location: San Francisco, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $7.5 Million
- Last Funding Amount: $2.5 Million (Latest Round: Sep 30, 2024)
Macro Oceans is a biotechnology startup focused on advancing ocean-based solutions for the environment. The company specializes in the research and development of sustainable products and technologies aimed at preserving and enhancing marine ecosystems. Their innovative approach is designed to address critical global challenges such as climate change, overfishing, and the degradation of ocean habitats.
Macro Oceans aims to harness the natural potential of the oceans to create solutions that promote biodiversity and sustainability. By exploring the intersection of biotechnology and marine ecosystems, they are working to revolutionize how humanity interacts with the ocean in a responsible and eco-friendly way.
12. Anebulo Pharmaceuticals
- Founded: 2020
- Location: Austin, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $9.4 Million
- Last Funding Amount: $1.9 Million (Latest Round: Nov 13, 2024)
Anebulo Pharmaceuticals is a biotechnology company focused on developing innovative therapies for the treatment of diseases caused by intoxication. Their pipeline includes therapies for conditions such as cannabinoid overdose and other acute toxin exposures, aiming to improve patient outcomes and reduce the burden of such medical emergencies.
The company is advancing its mission to bring novel, targeted treatments to market that can quickly and effectively reverse the effects of toxic exposures. Their proprietary drug candidates have the potential to significantly impact emergency medical care, offering solutions for conditions where no effective treatment currently exists.
13. Prolocor
- Founded: 2020
- Location: Philadelphia, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $6.9M
- Last Funding Amount: $1.7M (Latest Round: Feb 27, 2024)
Prolocor is a biotechnology company focused on developing innovative gene therapies for the treatment of cardiovascular diseases. Their core research aims to provide breakthrough solutions to patients suffering from heart disease, specifically targeting underlying genetic causes of the condition to enable more effective treatments.
By utilizing advanced gene-editing technologies and leveraging its proprietary platform, Prolocor is working on therapies that have the potential to revolutionize the way cardiovascular diseases are treated. Their focus on personalized medicine, combined with cutting-edge research in gene therapy, positions them at the forefront of the biotechnology field.
14. Catena Biosciences
- Founded: November 17, 2020
- Location: Berkeley, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $8.05M
- Last Funding Amount: $2.35M (Latest Round: May 10, 2024)
Catena Biosciences is a pioneering biotechnology company dedicated to revolutionizing the treatment of diseases associated with cellular dysfunction. Utilizing cutting-edge biotechnological research and a deep understanding of cellular biology, Catena develops targeted therapies that address the root causes of several complex health conditions, including neurodegenerative diseases and autoimmune disorders.
The company’s breakthrough approach combines innovative genetic engineering techniques with a robust therapeutic pipeline, aiming to enhance cellular repair mechanisms and slow disease progression at the cellular level. Catena Biosciences is committed to advancing regenerative medicine by focusing on improving cellular health and functionality, providing new hope for patients suffering from conditions that current treatments fail to adequately address.
15. Acenxion Biosystems
- Founded: Feb 27, 2020
- Location: Lawrence, Kansas, USA
- Industry: Biotechnology, Life Science, Medical
- Number of Employees: 1-10
- Total Funding Amount: $5.32M
- Last Funding Amount: $1.07M (Latest Round: Aug 14, 2024)
Acenxion Biosystems is an innovative biotechnology company on a mission to revolutionize healthcare with cutting-edge medical technologies. The company focuses on harnessing the power of biotechnology and life sciences to create treatments that address significant unmet medical needs.
Acenxion Biosystems is pioneering solutions in ophthalmic diseases and other critical health conditions, utilizing advanced biosystems and diagnostic tools to provide more effective and accessible therapies. The company’s expertise in medical device development and therapeutic innovations aims to improve patient quality of life, particularly in areas with limited treatment options.
16. Predicta Biosciences
- Founded: 2023
- Location: Boston, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $5.2M
- Last Funding Amount: $5.2M (Latest Round: Jul 16, 2024)
Predicta Biosciences is at the forefront of precision oncology, leveraging advanced multiomics and liquid biopsies to create groundbreaking diagnostic tools and therapies for cancer. With a focus on developing innovative solutions for cancer detection and treatment, Predicta Biosciences integrates cutting-edge technologies to address the complex challenges in oncology.
The company is committed to advancing personalized medicine by developing therapies that target specific biomarkers, offering patients more effective and tailored treatment options. Predicta’s multiomics approach combines genomics, proteomics, and other data types, providing a comprehensive understanding of cancer biology. This enables the development of more accurate diagnostics and the identification of novel immunotherapy targets.
17. Steel Therapeutics
- Founded: 2020
- Location: North Liberty, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $7.1M
- Last Funding Amount: $2M (Latest Round: Dec 5, 2024)
Steel Therapeutics is a cutting-edge biotechnology firm focused on developing breakthrough therapeutic solutions in the medical field. The company is committed to tackling some of the most complex health challenges through innovative research and novel drug discovery.
Steel Therapeutics specializes in improving the safety and efficacy of treatments by employing advanced scientific techniques and a patient-centric approach. The company’s portfolio includes promising therapies aimed at addressing critical diseases that lack effective treatments today. By leveraging the latest advancements in biotechnology, Steel Therapeutics aims to not only improve patient outcomes but also minimize adverse effects traditionally associated with many medical treatments.
18. TwoStep Therapeutics
- Founded: 2023
- Location: Palo Alto, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $6.5M
- Last Funding Amount: $6.5M (Latest Round: Jun 25, 2024)
TwoStep Therapeutics is a forward-thinking biotechnology company dedicated to developing innovative treatments targeting critical areas of health, with a focus on personalized medicine. The company works at the intersection of precision therapies and cutting-edge biotechnological research, bringing the future of healthcare to the present.
TwoStep Therapeutics is committed to addressing unmet medical needs by employing a comprehensive approach to drug discovery and development. The company leverages advanced technologies and scientific expertise to create therapies that target disease mechanisms more efficiently than traditional methods. By using state-of-the-art techniques in molecular biology and genomics, TwoStep Therapeutics aims to revolutionize the way we approach treatments for complex diseases.
19. Previse (Capsulomics)
- Founded: January 2020
- Location: Baltimore, USA
- Industry: Biotechnology
- Number of Employees: 11-50
- Total Funding Amount: $8.05M
- Last Funding Amount: $1.8M (Latest Round: Oct 22, 2024)
Previse (formerly known as Capsulomics) is a biotechnology company dedicated to revolutionizing healthcare through innovative therapies and diagnostics. With a focus on advancing scientific discovery, the company is actively working on creating solutions to tackle a wide range of complex diseases and health conditions.
Previse specializes in next-generation technologies and approaches in precision medicine, focusing on unlocking new potential for treating conditions that have traditionally been difficult to address. The company combines state-of-the-art research with cutting-edge technologies to bring transformative changes to the healthcare landscape.
20. CellVax Therapeutics Inc
- Founded: 2020
- Location: Miami, Florida, USA
- Industry: Biotechnology
- Number of Employees: 1-10
- Total Funding Amount: $7.31M
- Last Funding Amount: $2.08M (Latest Round: Oct 4, 2024)
CellVax Therapeutics Inc. is a cutting-edge biotechnology company specializing in the development of innovative cell-based therapies aimed at treating a variety of diseases, particularly in the areas of immunotherapy and regenerative medicine. With a focus on precision medicine, CellVax is committed to creating personalized therapeutic solutions that improve patient outcomes by harnessing the power of the immune system.
The company’s proprietary technology platform enables the development of targeted treatments with the potential to revolutionize the treatment of chronic and life-threatening conditions. Their interdisciplinary approach combines advanced research in cell biology, genomics, and immunology to develop novel therapies that can address critical unmet medical needs in oncology, autoimmune disorders, and more.
Conclusion
These 20 biotech startups, founded after 2020 and raising $5M–$10M, are at the forefront of groundbreaking innovations in healthcare and biotechnology. With fresh funding, they are advancing new treatments, diagnostics, and technologies aimed at improving patient outcomes and addressing global health challenges. Their innovations promise to shape the future of medicine, making healthcare more personalized, efficient, and accessible.
FAQs
Q. What are biotech startups, and why are they important?
Answer: Biotech startups are innovative companies that focus on developing new technologies, treatments, or solutions using biological processes and materials. They play a crucial role in advancing healthcare, sustainability, and agriculture by tackling some of the world’s most pressing challenges.
Q. What challenges do these biotech startups face?
Answer: Despite their innovation, these startups face challenges such as regulatory hurdles, high development costs, and the time-intensive nature of bringing biotech solutions to market. However, the substantial funding they’ve secured positions them well to overcome these challenges and scale their impact.
Q. What’s the future outlook for these biotech Startups?
Answer: Given the rapid advancements in biotech and the growing demand for innovative solutions, these startups are well-positioned for significant growth. As they continue to secure funding and scale their operations, they are expected to make a lasting impact on their respective industries and potentially transform healthcare and sustainability practices globally.